南京大学学报(自然科学版)
南京大學學報(自然科學版)
남경대학학보(자연과학판)
JOURNAL OF NANJING UNIVERSITY(NATURAL SCIENCES)
2005年
5期
478-488
,共11页
抑肽酶%丝氨酸蛋白酶%Kunitz抑制剂%抑制作用%尿激酶型纤溶酶原激活剂%组织型纤溶酶原激活剂
抑肽酶%絲氨痠蛋白酶%Kunitz抑製劑%抑製作用%尿激酶型纖溶酶原激活劑%組織型纖溶酶原激活劑
억태매%사안산단백매%Kunitz억제제%억제작용%뇨격매형섬용매원격활제%조직형섬용매원격활제
aprotinin%serine protease%Kunitz inhibitor%inhibition%urokinase-type plasminogen activator%tissue-type plasminogen activator
抑肽酶属Kunitz抑制剂家族成员,能够抑制激肽释放酶、纤溶酶及胰蛋白酶的蛋白水解活性.研究表明,抑肽酶能够抑制尿激酶型-纤溶酶原激活剂(u-PA)和组织型-纤溶酶原激活剂(t-PA)对纤溶酶原的激活,但不影响u-PA和t-PA对小分子底物的酰胺水解活性.用u-PA研究了上述作用的机制,发现抑肽酶与u-PA的丝氨酸蛋白酶功能区特异性结合,而与纤溶酶原没有相互作用.抑肽酶与u-PA的结合并不阻断u-PA的活性位点,因为u-PA对小分子底物的水解活性仍然保持.上述发现提示抑肽酶可能存在另一种抑制作用模式,该模式不同于以前报道的关于Kunitz抑制剂或纤溶酶原激活酶抑制剂的作用.由于人体内的Kunitz抑制剂与抑肽酶在结构上非常相似,根据研究结果,推测体内纤溶酶原的激活作用并非仅受丝氨酸蛋白酶抑制剂的控制.
抑肽酶屬Kunitz抑製劑傢族成員,能夠抑製激肽釋放酶、纖溶酶及胰蛋白酶的蛋白水解活性.研究錶明,抑肽酶能夠抑製尿激酶型-纖溶酶原激活劑(u-PA)和組織型-纖溶酶原激活劑(t-PA)對纖溶酶原的激活,但不影響u-PA和t-PA對小分子底物的酰胺水解活性.用u-PA研究瞭上述作用的機製,髮現抑肽酶與u-PA的絲氨痠蛋白酶功能區特異性結閤,而與纖溶酶原沒有相互作用.抑肽酶與u-PA的結閤併不阻斷u-PA的活性位點,因為u-PA對小分子底物的水解活性仍然保持.上述髮現提示抑肽酶可能存在另一種抑製作用模式,該模式不同于以前報道的關于Kunitz抑製劑或纖溶酶原激活酶抑製劑的作用.由于人體內的Kunitz抑製劑與抑肽酶在結構上非常相似,根據研究結果,推測體內纖溶酶原的激活作用併非僅受絲氨痠蛋白酶抑製劑的控製.
억태매속Kunitz억제제가족성원,능구억제격태석방매、섬용매급이단백매적단백수해활성.연구표명,억태매능구억제뇨격매형-섬용매원격활제(u-PA)화조직형-섬용매원격활제(t-PA)대섬용매원적격활,단불영향u-PA화t-PA대소분자저물적선알수해활성.용u-PA연구료상술작용적궤제,발현억태매여u-PA적사안산단백매공능구특이성결합,이여섬용매원몰유상호작용.억태매여u-PA적결합병불조단u-PA적활성위점,인위u-PA대소분자저물적수해활성잉연보지.상술발현제시억태매가능존재령일충억제작용모식,해모식불동우이전보도적관우Kunitz억제제혹섬용매원격활매억제제적작용.유우인체내적Kunitz억제제여억태매재결구상비상상사,근거연구결과,추측체내섬용매원적격활작용병비부수사안산단백매억제제적공제.
Aprotinin, a natural inhibitor belonging to the Kunitz family, is known to inhibit proteolysis of kallikrein, plasmin and trypsin. In the present study, aprotinin was shown to inhibit plasminogen activation by urokinase-type plasminogen activator (u-PA) and tissue-type plasminogen activator (t-PA). By contrast,the amidolytic activities of these activators against their synthetic substrates were not inhibited by aprotinin.The mechanism of action was investigated using u-PA, and it was shown that aprotinin bound specifically to u-PA but not to plasminogen. Since aprotinin was also found to bind to low molecular weight u-PA, the binding site was therefore concluded to be the protease domain. However, it did not directly block the active site of u-PA, since the u-PA activity against the synthetic substrate was preserved. The findings suggested a model of action which has not been previously described for either Kunitz inhibitors or plasminogen activator inhibitors.Since the structure of aprotinin closely resembles certain human Kunitz inhibitors, these studies prompted the hypothesis that the pathway of plasminogen activation in vivo may not be soldy under the control of serpins, as is currently believed.